Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed vs standard administration of fosaprepitant and/or olanzapine for prevention of cisplatin-induced nausea and vomiting
ChiCTR2000040675Phase 4Not yet recruiting
- Sponsor
- Ordos Central Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fosaprepitant and olanzapine in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Ordos Central Hospital. Primary endpoint: overall phase total control rate. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
fosaprepitantolanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ChiCTR2000040675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040675.